Topics - Industry & economy

The Transatlantic Trade and Investment Partnership (TTIP)

The Transatlantic Trade and Investment Partnership (TTIP) aims to create more open trade between the EU and the U.S. Strengthening the world’s most important trading relationship can serve as a key platform to bring quicker new treatment options to patients. TTIP has the potential to facilitate the development of new medicines and improve health outcomes and support new long-term economic benefits.


TTIP: What's in it for patients?

 

OUR PERSPECTIVE

The innovative pharmaceutical industry supports a comprehensive and ambitious agreement that promotes regulatory compatibility, strengthens intellectual property protection, and enhances patient access to innovative medicines. Moreover, increased regulatory compatibility can, for example, be expected to have a particularly positive impact on smaller companies and collaborations that are central to the broader life sciences ecosystem. EFPIA strongly believes that a strong TTIP agreement can help accelerate global development of medicines and enhance patient access to much-needed innovative medicines.